EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

RegionSizeR– A Novel App for Regional Sample Size Planning in MRCTs

Guannan Sun, Xin Sun, Huijuan Su, Yuqin Liao, Di Wei, Hanqing Ma, Xinyu Li, Ran Fan, Xiaowei Ren

Therapeutic Innovation & Regulatory Science · 2024

DOI: 10.1007/s43441-024-00679-6 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Therapeutic Innovation & Regulatory Science, 2024. Verfasst von Guannan Sun und 8 weiteren Autor:innen. Beteiligte Einrichtung: Pharmaceuticals Statistics and Data Insights, Bayer Healthcare Co. Ltd. Research & Development, 6F Parkview Green Blk B, No.9 Dongdaqiao Road, Beijin…. Hauptthemen laut MEDLINE: Research Design. Die Arbeit nennt 11 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In multi-regional clinical trials, planning the sample size for participating regions is essential for the evaluation of the treatment effect consistency across regions. Based on the MRCT design and sample size allocation to regions, consistency probability is usually used to predict the consistent trend between regions and the overall population, while preserving a certain proportion of the overall treatment effect. Specific enrollment characteristics in a region of interest should also be considered during the time of the sample size planning. To facilitate efficient and harmonized regional sample size planning, we have developed RegionSizeR , a comprehensive and user-friendly interactive web-based R shiny application that can be obtained from https://github.com/rsr-ss/RegionSizeR . This simulation-based app can serve as an initial point for discussions on sample size allocation plans, following preservation of treatment effect method in ICH E17. The app accommodates various types of endpoints and designs, including continuous, binary, and time-to-event endpoints, for superiority, non-inferiority, and MCP-Mod designs. To ensure the validity of this app, independent testing is conducted allowing a discrepancy of no more than 1% across all results considering various scenarios.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Research DesignSample SizeHumansSoftwareMulticenter Studies as TopicComputer SimulationClinical Trials as Topic

Stichwörter der Autor:innen

Clinical trialConsistency probabilityPreservation of treatment effectRegions joining MRCTSample size

Autor:innen und Institutionen

  • Pharmaceuticals Statistics and Data Insights, Bayer Healthcare Co. Ltd. Research & Development, 6F Parkview Green Blk B, No.9 Dongdaqiao Road, Beijing, China.
  • Bayer US LLC, Whippany, NJ, USA.
  • Akesobio Inc, Nanjing, China.
  • Pharmaceuticals Statistics and Data Insights, Bayer Healthcare Co. Ltd. Research & Development, 6F Parkview Green Blk B, No.9 Dongdaqiao Road, Beijing, China. Xiaowei.ren@bayer.com.

Zitieren

APA

Sun, G., Sun, X., Su, H., Liao, Y., Wei, D., Ma, H., Li, X., Fan, R., & Ren, X. (2024). RegionSizeR– A Novel App for Regional Sample Size Planning in MRCTs. Therapeutic Innovation & Regulatory Science. https://doi.org/10.1007/s43441-024-00679-6

Vancouver

Sun G, Sun X, Su H, Liao Y, Wei D, Ma H, et al. RegionSizeR– A Novel App for Regional Sample Size Planning in MRCTs. Therapeutic Innovation & Regulatory Science. 2024. doi:10.1007/s43441-024-00679-6

BibTeX
@article{Sun2024,
  author = {Sun, Guannan and Sun, Xin and Su, Huijuan and Liao, Yuqin and Wei, Di and Ma, Hanqing and Li, Xinyu and Fan, Ran and Ren, Xiaowei},
  title = {RegionSizeR– A Novel App for Regional Sample Size Planning in MRCTs},
  journal = {Therapeutic Innovation & Regulatory Science},
  year = {2024},
  doi = {10.1007/s43441-024-00679-6}
}
Kostenlos starten →